Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. (Elite) is a specialty pharmaceutical company principally engaged in the development and manufacture of oral, controlled-release products. The Company’s activity includes improving off-patent drug products for life cycle management and developing generic versions of controlled-release drug products. Its technology is applicable to develop delayed, sustained or targeted-release pellets, capsules, tablets, granules and powders. As of March 31, 2009, the Company had two products, Lodrane 24 and Lodrane 24D, being sold commercially, and a pipeline of five additional drug candidates under active development in the therapeutic areas that include pain management, allergy and infection. Of the products under development, ELI-216, a once-a-day, abuse-deterrent oxycodone product, and ELI-154, a once-a-day oxycodone product, are in clinical trials, and Elite has completed pilot studies on two of its other generic product candidates.

Contact Details

Office Address

Elite Pharmaceuticals, Inc.
165 Ludlow Ave.
Northvale, NJ, USA 07647
Phone: (201) 750-2646
Fax: (201) 750-2755


Chairman and CEO

Jerry I. Treppel

President and COO

Christopher C. (Chris) Dick

Business Reviews for Elite Pharmaceuticals, Inc.

Related Companies